Thursday, March 28

EMA expects data on Omicron-specific vaccine as early as April


Article content

The European Medicines Agency’s (EMA) leading vaccine expert said that data on COVID-19 vaccines tailored for the Omicron variant should be available between April and July this year, potentially paving the way for a decision by the summer.

Vaccine makers such as Moderna and Pfizer have begun testing COVID-19 vaccines designed to target the Omicron coronavirus variant. (Reporting by Manas Mishra and Ludwig Burger Editing by David Goodman)



financialpost.com